Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 113 participants.

Also called NCT03271710

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 113 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03271710
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03271710. Allocation not applicable; no masking; primary purpose treatment. Start 2017-09-01 (actual); primary completion 2018-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
Acronym
ENTRAP
Condition
Peripheral Arterial Disease
Condition
Atherosclerosis of Femoral Artery
Intervention (Device)
peripheral balloon angioplasty
Lead sponsor
Contego Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03271710
Content hash
5b3f2f9872424fc5653308e6e5691cca13aa452668ae5c93d7437659ebd435a1